ARTA
AKCA

A.R.T. Advisors’s Akcea Therapeutics Inc AKCA Stock Holding History

A.R.T. Advisors’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-53,560
Closed -$907K – 1241
2019
Q4 		$907K Buy
53,560
+24,653
+85% +$459K 0.04% 601
2019
Q3 		$445K Buy
+28,907
New +$616K 0.02% 905
2019
Q2 		– Sell
-14,707
Closed -$417K – 1765
2019
Q1 		$417K Buy
+14,707
New +$428K 0.03% 812
2018
Q1 		– Sell
-13,800
Closed -$239K – 1872
2017
Q4 		$239K Buy
+13,800
New +$271K 0.01% 1110

Other funds holding AKCA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

A.R.T. Advisors's AKCA Position: Q1 2020 in Review

A.R.T. Advisors sold out of Akcea Therapeutics Inc (AKCA) in Q1 2020, closing a stake of 53,560 shares — an estimated $907K sold.

A.R.T. Advisors first reported a position in AKCA in Q4 2017 and held it in 4 quarters. The position peaked at $907K in Q4 2019. 77 funds tracked by Wall St. Rank hold AKCA as of Q1 2020.

  • A.R.T. Advisors reported no remaining Akcea Therapeutics Inc position as of Q1 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 53,560 Akcea Therapeutics Inc shares in Q1 2020, an estimated $907K.
  • A.R.T. Advisors first reported a position in Akcea Therapeutics Inc in Q4 2017 and held it in 4 quarters.
  • A.R.T. Advisors's Akcea Therapeutics Inc position peaked at $907K in Q4 2019.
  • 77 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.